Erasca's share price nosedived 53% after a patient died in its Phase I trial of ERAS-0015, and rival Revolution Medicine ...

j. Craig Venter, PhD [Heather Kowalski] J. Craig Venter, PhD, the founder, board chair, and CEO of the J. Craig Venter Institute (JCVI) has died in San Diego following a brief hospitalization for ...

Findings identify strategy for boosting anticancer immunity and potentially a new tool for delivering genetic payloads to ...

Scientists have long known that myelin doesn’t appear everywhere in the brain at once. Some regions myelinate early, others much later, and the timing shapes everything from motor development to ...

By deploying a "tag and sort" fix using E3 ligases, scientists successfully cleared the protein buildup and restored T-cell ...

Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

Study finds that a classically anaerobic bacterium, ETBF, can benefit from, and even help create, an oxygen-rich environment.

Companies are adopting diverse approaches to reducing unwanted toxicities associated with cell and gene therapy.

The right approaches are demonstrating that it is possible to breach the defensively designed blood-brain barrier despite its ...

IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...